Author Question: A patient has been diagnosed with myxedema. She currently takes ibuprofen (Motrin) for knee pain. ... (Read 58 times)

Jipu 123 · **on:** Jul 23, 2018

A patient has been diagnosed with myxedema. She currently takes ibuprofen (Motrin) for knee pain. For what is this patient at increased risk?

A) Nephrotoxicity
B) Pulmonary congestion
C) Tachycardia
D) Apnea

Question 2

A patient is to be switched from fluoxetine (Prozac) to isocarboxazid (Marplan). What patient education is most important when changing from fluoxetine (Prozac)?

A) Wait 5 days before starting isocarboxazid (Marplan).
B) Wait 1 week before starting isocarboxazid (Marplan).
C) Wait 2 weeks before starting isocarboxazid (Marplan).
D) Wait 5 weeks before starting isocarboxazid (Marplan).

steff9894 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
Feedback:
A patient diagnosed with myxedema cannot metabolize and excrete drugs, so she is at an increased risk of developing nephrotoxicity. Pulmonary congestion, tachycardia, and apnea are not adverse effects related to myxedema or the administration of ibuprofen (Motrin).

Answer to Question 2

D
Feedback:
If a patient is taking fluoxetine (Prozac) and is being switched to isocarboxazid (Marplan), the fluoxetine should be discontinued at least 5 weeks before starting the MAO inhibitor. Waiting less time than this before starting the isocarboxazid (Marplan) will place the patient at risk for serotonin syndrome.